InsidersTradesSigma
Track the Genovis AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Healthcare & Pharma sector, Genovis AB has logged 8 insider filings. Market capitalisation: €1.3bn. The latest transaction was filed on 15 May 2026 (Purchase). Among the most active insiders: Steven Jordan. Every trade is free.
8
Insider Decl.
n/a
Thresholds
€155,849
6 ops.
Buy Volume
€1m
2 ops.
Sell Volume
32Σ signal
Fundamental score
Ranked 14,775 of 29,063 companies
51.6
score / 100
Value32
Quality71
FCF yld1.3%
Earn yld1.6%
EV/EBITDA36.6x
ROE7.5%
Gross mgn90%
Net mgn18%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 May 2026
Declarations8 total
4,146 shares@ €1.670.0005% mcap50.0% of flowAktieISIN SE0002485979FI:csv-3038ed09a69538b751f4
4,146 shares@ SEK 18.4490.0005% mcap100.0% of flowAktieISIN SE0002485979FI:A003Y639-1
2,470 shares@ €1.58930.0003% mcap100.0% of flowAktieISIN SE0002485979FI:A003W421-1
13,000 shares@ €1.63640.0016% mcap48.8% of flowAktieISIN SE0002485979FI:A003W055-1
38,340 shares@ €2.4640.0072% mcap100.0% of flowAktieISIN SE0002485979FI:A003O980-1
255,653 shares@ €2.34420.044% mcap52.5% of flowAktieISIN SE0002485979FI:A003O854-1
235,000 shares@ €2.30380.040% mcap47.5% of flowAktieISIN SE0002485979FI:A003M263-1
10,418 shares@ €2.14360.0016% mcap51.2% of flowAktieISIN SE0002485979FI:A003M248-1
8 of 8 declarations
Acerca de Genovis AB
Genovis AB es una empresa centrada en el desarrollo de tecnologías para biofarmacéuticos, particularmente herramientas para la modificación de anticuerpos. Cotiza en la bolsa XSTO.
